Pharma and biotech companies face a pivotal next step in addressing the increased complexity of production while balancing mounting cost pressures with the need to ensure product quality, security of supply and regulatory compliance. Findings from AspenTech® and Longitude’s recent market survey revealed that digital culture and technology adoption provide a competitive edge – but adoption is slow.
This report will cover key topics such as:
- How companies are effectively utilizing data throughout the entire manufacturing process network
- Barriers companies are facing using artificial intelligence and machine learning technology to derive value from data
- Impact of the COVID-19 pandemic across organizations, from R&D and vaccine manufacturing capacity to security of supply
- The four key steps to adaptability, resilience and lasting success
Learn how Pharmaceutical and Biotech companies are responding to unprecedented market volatility, increasing complexity of production and potential risk factors across the value chain.